We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Gastroenterology

Journal Scan / Research · December 09, 2019

Direct-Acting Antiviral Therapy for HCV Infection Is Associated With Increased Survival in Patients With a History of HCC



Additional Info

Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection Is Associated With Increased Survival in Patients With a History of Hepatocellular Carcinoma
Gastroenterology 2019 Nov 01;157(5)1253-1263.e2, AG Singal, NE Rich, N Mehta, AD Branch, A Pillai, M Hoteit, M Volk, M Odewole, S Scaglione, J Guy, A Said, JJ Feld, BV John, C Frenette, P Mantry, AS Rangnekar, O Oloruntoba, M Leise, JH Jou, KR Bhamidimarri, L Kulik, GN Ioannou, A Huang, T Tran, H Samant, R Dhanasekaran, A Duarte-Rojo, R Salgia, S Eswaran, P Jalal, A Flores, SK Satapathy, S Kagan, P Gopal, R Wong, ND Parikh, CC Murphy

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading